Dekompanse Kalp Yetmezliği Bulguları ile Başvuran Bir Primer Efüzyon Lenfoma Olgusu

Naciye Demirel Yıldırım; Naciye  Demirel Yıldırım; Ercan Bıçakcı; Ercan Bıçakcı; Tuğrul Elverdi; Tuğrul Elverdi; Mustafa Nuri Yenerel; Reyhan Diz Küçükkaya; Reyhan Diz Küçükkaya; Öner Doğan; Meliha Nalçacı; Meliha Nalçacı

A Case Applied With Decompensated Heart Failure Findings Diagnosed as Primary Effusion Lymphoma

Year 2008, Volume: 2008 Issue: 2, 152 - 155, 01.02.2008

Naciye Demirel Yıldırım Naciye Demirel Yıldırım Ercan Bıçakcı Ercan Bıçakcı Tuğrul Elverdi Tuğrul Elverdi Mustafa Nuri Yenerel Reyhan Diz Küçükkaya Reyhan Diz Küçükkaya Öner Doğan Meliha Nalçacı Meliha Nalçacı

Abstract

Primary Effusion Lymphoma (PEL) is an infrequent subtype of Non-Hodgkin`s Lymphoma which is characterized by lymphomatous effusions in body cavities, not-associated with mass lesions. Generally PEL is reported in immunocompromised patients infected with human immunodeficiency virus (HIV) and Human Herpes Virus-8 (HHV-8). Recently HIV and HHV-8 negative cases were also reported. Here, we report a 76 year-old man with HIV and HHV-8 negative PEL successfully treated with R-COP chemotherapy protocol. Turkish Başlık: Dekompanse Kalp Yetmezliği Bulguları ile Başvuran Bir Primer Efüzyon Lenfoma Olgusu Anahtar Kelimeler: Primer efüzyon lenfoması Primer efüzyon lenfoması (PEL), vücut boşluklarının seröz zarlarda solid kitle ilişkisiz olarak gelişen ve lenfomatöz efüzyon ile kendini gösteren, nadir bir Hodgkin dışı lenfoma alt grubudur. Primer efüzyon lenfoması, özellikle HIV (Human immunodeficiency virus) ve HHV-8 (Human herpesvirus-8) ile infekte bağışıklığı baskılanmış kişilerde tanımlanmış olsa da, son yıllarda HIV veya HHV-8 infekte olmayan olgular da bildirilmektedir. Bu yazıda, 76 yaşında dekompanse kalp yetmezliği tablosu ile başvuran, HIV ve HHV-8 negatif PEL tanısı konularak R-COP protokolü ile başarıyla tedavi edilen bir olgu sunuldu.

Keywords

Primary effusion lymphoma

References

Jenkins C, Sorour Y, Blake E, Elliot R, Al-Sabah AI, Green J. Human-immunodeficiency-virus-negative, human-herpes-virus-8-negative abdominal cav- ity primary effusion lymphoma. Clin Oncol (R Coll Radiol) 2005;17:636-8.
Matsumoto Y, Nomura K, Ueda K, Satoh K, Yasuda N, Taki T, et al. Human herpesvirus 8-negative malignant effusion lymphoma: a distinct clinical entity and successful treatment with rituximab. Leuk Lymphoma 2005;46:415-9.
Pérez CL, Rudoy S. Anti-CD20 monoclonal anti- body treatment of human herpesvirus 8-associated, body cavity-based lymphoma with an unusual phenotype in a human immunodeficiency virus- negative patient. Clin Diagn Lab Immunol 2001; 8:993-6.
Kamihira S, Jiann C, Uemura A, Tsuruda K, Hasegawa H, Sugahara K, et al. A subtype of aggres- sive B-cell lymphoma with an unusual presentation of effusion without masses. Leuk Lymphoma 2006; 47:1991-3.
Lechapt-Zalcman E, Challine D, Delfau-Larue MH, Haioun C, Desvaux D, Gaulard P. Association of pri- mary pleural effusion lymphoma of T-cell origin and human herpesvirus 8 in a human immunodeficiency virus-seronegative man. Arch Pathol Lab Med 2001; 125:1246-8.
Shimazaki M, Fujita M, Tsukamoto K, Matsuki T, Iwata M, Takahashi H, et al. An unusual case of pri- mary effusion lymphoma in a HIV-negative patient not pathogenetically associated with HHV8. Eur J Haematol 2003;71:62-7.
Shirokov D, Kadyrova E, Anokhina M, Kondratyeva T, Gourtsevich V, Tupitsyn N. A case of HHV-8- associated HIV-negative primary effusion lympho- ma in Moscow. J Med Virol 2007;79:270-7.
Das DK. Serous effusions in malignant lymphomas: a review.Diagn Cytopathol 2006;34:335-47.
Youngster I, Vaisben E, Cohen H, Nassar F. An unusu- al cause of pleural effusion. Age Ageing 2006; 35:94-6.
Lim ST, Rubin N, Said J, Levine AM. Primary effu- sion lymphoma: successful treatment with highly active antiretroviral therapy and rituximab. Ann Hematol 2005;84:551-2.